Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ethan J Anderson

Showing results (1-10 of 69) with videos related to

Pageof 7
Sort By:
Chemical Research in Toxicology|October 5, 2021
A Catecholaldehyde Metabolite of Norepinephrine Induces Myofibroblast Activation and Toxicity via the Receptor for Advanced Glycation Endproducts: Mitigating Role of l-CarnosineT Blake Monroe, Ethan J Anderson
American Journal of Physiology. Cell Physiology|October 28, 2005
Type II skeletal myofibers possess unique properties that potentiate mitochondrial H(2)O(2) generationEthan J Anderson, P Darrell Neufer
Cardiovascular Toxicology|June 10, 2025
Not 'Inactive' After All: Cardiotoxic Mechanisms of Catecholamine Metabolism by Monoamine OxidaseRachel M Crawford, Ethan J Anderson
Bio-Protocol|March 3, 2021
A Highly Sensitive, Reproducible Assay for Determining 4-hydroxynonenal Protein Adducts in Biological MaterialT Blake Monroe, Ethan J Anderson
F1000 Medicine Reports|July 18, 2012
Stressing the heart of the matter: re-thinking the mechanisms underlying therapeutic effects of n-3 polyunsaturated fatty acidsEthan J Anderson, David A Taylor
The Journal of Biological Chemistry|September 1, 2007
Induction of endogenous uncoupling protein 3 suppresses mitochondrial oxidant emission during fatty acid-supported respirationEthan J Anderson, Hanae Yamazaki, P Darrell Neufer
Clinical and Experimental Pharmacology & Physiology|November 10, 2011
Mitochondria as a source and target of lipid peroxidation products in healthy and diseased heartEthan J Anderson, Lalage A Katunga, Monte S Willis
Current Pharmaceutical Design|April 20, 2022
Interaction of Vitamin D and Corticosteroid Use in Hospitalized COVID-19 Patients: A Potential Explanation for Inconsistent Findings in the LiteratureJimmy T Efird, Ethan J Anderson, Charulata Jindal, et al.
Current Opinion in Pharmacology|May 22, 2017
Biogenic Aldehydes as Therapeutic Targets for Cardiovascular DiseaseMargaret-Ann M Nelson, Shahid P Baba, Ethan J Anderson
The Biochemical Journal|September 2, 2011
Aldehyde stress and up-regulation of Nrf2-mediated antioxidant systems accompany functional adaptations in cardiac mitochondria from mice fed n-3 polyunsaturated fatty acidsEthan J Anderson, Kathleen Thayne, Mitchel Harris, et al.
Pageof 7

Showing results (1-10 of 69) with videos related to

Sort By:
Pageof 7
Chemical Research in Toxicology|October 5, 2021
A Catecholaldehyde Metabolite of Norepinephrine Induces Myofibroblast Activation and Toxicity via the Receptor for Advanced Glycation Endproducts: Mitigating Role of l-CarnosineT Blake Monroe, Ethan J Anderson
American Journal of Physiology. Cell Physiology|October 28, 2005
Type II skeletal myofibers possess unique properties that potentiate mitochondrial H(2)O(2) generationEthan J Anderson, P Darrell Neufer
Cardiovascular Toxicology|June 10, 2025
Not 'Inactive' After All: Cardiotoxic Mechanisms of Catecholamine Metabolism by Monoamine OxidaseRachel M Crawford, Ethan J Anderson
Bio-Protocol|March 3, 2021
A Highly Sensitive, Reproducible Assay for Determining 4-hydroxynonenal Protein Adducts in Biological MaterialT Blake Monroe, Ethan J Anderson
F1000 Medicine Reports|July 18, 2012
Stressing the heart of the matter: re-thinking the mechanisms underlying therapeutic effects of n-3 polyunsaturated fatty acidsEthan J Anderson, David A Taylor
The Journal of Biological Chemistry|September 1, 2007
Induction of endogenous uncoupling protein 3 suppresses mitochondrial oxidant emission during fatty acid-supported respirationEthan J Anderson, Hanae Yamazaki, P Darrell Neufer
Clinical and Experimental Pharmacology & Physiology|November 10, 2011
Mitochondria as a source and target of lipid peroxidation products in healthy and diseased heartEthan J Anderson, Lalage A Katunga, Monte S Willis
Current Pharmaceutical Design|April 20, 2022
Interaction of Vitamin D and Corticosteroid Use in Hospitalized COVID-19 Patients: A Potential Explanation for Inconsistent Findings in the LiteratureJimmy T Efird, Ethan J Anderson, Charulata Jindal, et al.
Current Opinion in Pharmacology|May 22, 2017
Biogenic Aldehydes as Therapeutic Targets for Cardiovascular DiseaseMargaret-Ann M Nelson, Shahid P Baba, Ethan J Anderson
The Biochemical Journal|September 2, 2011
Aldehyde stress and up-regulation of Nrf2-mediated antioxidant systems accompany functional adaptations in cardiac mitochondria from mice fed n-3 polyunsaturated fatty acidsEthan J Anderson, Kathleen Thayne, Mitchel Harris, et al.
Pageof 7